Kestra Private Wealth Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.5M Sell
39,487
-2,958
-7% -$414K 0.07% 304
2025
Q4
$5.21M Buy
42,445
+1,604
+4% +$195K 0.06% 304
2025
Q3
$4.53M Buy
40,841
+5,711
+16% +$649K 0.06% 321
2025
Q2
$3.89M Buy
35,130
+5,534
+19% +$589K 0.06% 326
2025
Q1
$3.32M Buy
29,596
+228
+0.8% +$23.5K 0.06% 339
2024
Q4
$2.71M Buy
29,368
+1,247
+4% +$112K 0.05% 359
2024
Q3
$2.36M Sell
28,121
-6,876
-20% -$525K 0.04% 386
2024
Q2
$2.4M Sell
34,997
-7,202
-17% -$481K 0.05% 351
2024
Q1
$3.09M Sell
42,199
-4,446
-10% -$342K 0.07% 280
2023
Q4
$3.78M Buy
46,645
+7,257
+18% +$565K 0.1% 224
2023
Q3
$2.95M Buy
39,388
+1,319
+3% +$101K 0.09% 239
2023
Q2
$2.93M Buy
38,069
+2,606
+7% +$208K 0.1% 220
2023
Q1
$2.94M Buy
35,463
+12,129
+52% +$1M 0.12% 192
2022
Q4
$2M Sell
23,334
-2,097
-8% -$166K 0.1% 229
2022
Q3
$1.57M Sell
25,431
-3,711
-13% -$234K 0.09% 253
2022
Q2
$1.8M Sell
29,142
-2,730
-9% -$169K 0.1% 238
2022
Q1
$1.9M Buy
31,872
+4,816
+18% +$308K 0.09% 231
2021
Q4
$1.97M Sell
27,056
-13,479
-33% -$928K 0.09% 228
2021
Q3
$2.83M Buy
40,535
+2,483
+7% +$174K 0.16% 150
2021
Q2
$2.62M Buy
38,052
+1,235
+3% +$82.5K 0.16% 145
2021
Q1
$2.38M Sell
36,817
-1,454
-4% -$93.8K 0.17% 149
2020
Q4
$2.17M Buy
38,271
+15,917
+71% +$960K 0.16% 149
2020
Q3
$1.44M Buy
+22,354
New +$1.55M 0.12% 181

Other funds holding GILD

Kestra Private Wealth Services's GILD Position: Q1 2026 in Review

Kestra Private Wealth Services reduced its Gilead Sciences (GILD) stake by 7% in Q1 2026, selling an estimated $414K and leaving 39,487 shares worth $5.5M. The position accounts for 0.07% of the portfolio, ranked #304.

Kestra Private Wealth Services first reported a position in GILD in Q3 2020 and has held it in 23 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Kestra Private Wealth Services held 39,487 shares of Gilead Sciences worth $5.5M as of Q1 2026.
  • Kestra Private Wealth Services sold 2,958 Gilead Sciences shares in Q1 2026, an estimated $414K.
  • Gilead Sciences made up 0.07% of Kestra Private Wealth Services's portfolio in Q1 2026, its #304 holding.
  • Kestra Private Wealth Services first reported a position in Gilead Sciences in Q3 2020 and has held it in 23 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.